Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$724.87 - $909.04 $200,064 - $250,895
276 New
276 $249,000
Q1 2023

May 08, 2023

SELL
$310.63 - $364.82 $36,033 - $42,319
-116 Reduced 72.96%
43 $14,000
Q4 2022

Jan 25, 2023

SELL
$321.55 - $374.67 $964 - $1,124
-3 Reduced 1.85%
159 $58,000
Q3 2022

Nov 02, 2022

SELL
$296.48 - $337.87 $201,013 - $229,075
-678 Reduced 80.71%
162 $52,000
Q2 2022

Jul 28, 2022

BUY
$278.73 - $327.27 $234,133 - $274,906
840 New
840 $272,000
Q3 2021

Nov 09, 2021

SELL
$221.6 - $272.71 $11,080 - $13,635
-50 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$164.32 - $212.72 $23,662 - $30,631
-144 Reduced 74.23%
50 $9,000
Q4 2020

Feb 08, 2021

BUY
$130.46 - $172.63 $18,786 - $24,858
144 Added 288.0%
194 $33,000
Q3 2020

Nov 04, 2020

SELL
$146.22 - $169.13 $146 - $169
-1 Reduced 1.96%
50 $7,000
Q2 2020

Aug 12, 2020

BUY
$136.42 - $164.18 $136 - $164
1 Added 2.0%
51 $8,000
Q4 2019

Jan 28, 2020

BUY
$106.92 - $132.43 $5,346 - $6,621
50 New
50 $7,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $691B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sageworth Trust CO Portfolio

Follow Sageworth Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sageworth Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Sageworth Trust CO with notifications on news.